Valentine M Macaulay Selected Research

Valentine M Macaulay Research Topics

Disease

23	Neoplasms (Cancer) 04/2023 - 05/2002
9	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 05/2002
3	Melanoma (Melanoma, Malignant) 04/2023 - 01/2004
3	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2007
3	Kidney Neoplasms (Kidney Cancer) 09/2011 - 06/2009
2	Squamous Cell Carcinoma of Head and Neck 11/2019 - 06/2015
2	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 06/2009
2	Carcinogenesis 06/2015 - 10/2008
1	Necrosis 04/2023
1	Glioma (Gliomas) 01/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2019
1	Endocrine Gland Neoplasms (Cancer, Endocrine) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Skin Diseases (Skin Disease) 01/2019
1	Frailty 01/2019
1	Acne Vulgaris 01/2019
1	Acromegaly 01/2019
1	Graves Ophthalmopathy 01/2019
1	Hyperglycemia 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Chordoma 01/2016
1	Starvation 11/2015
1	Colorectal Neoplasms (Colorectal Cancer) 06/2015
1	Sarcoma (Soft Tissue Sarcoma) 10/2014
1	Hereditary leiomyomatosis and renal cell cancer 09/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2007

Drug/Important Bio-Agent (IBA)

12	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2020 - 05/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2004
4	AntibodiesIBA 01/2019 - 08/2010
4	Proteins (Proteins, Gene)FDA Link 10/2014 - 05/2002
3	Insulin-Like PeptidesIBA 10/2023 - 10/2017
3	Biomarkers (Surrogate Marker)IBA 11/2019 - 09/2011
2	xentuzumabIBA 10/2023 - 01/2022
2	LigandsIBA 04/2023 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2023 - 10/2014
2	Epidermal Growth Factor (EGF)IBA 11/2019 - 04/2007
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 10/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019 - 05/2002
2	Insulin ReceptorIBA 01/2019 - 10/2008
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2019 - 10/2017
2	Formaldehyde (Formol)FDA Link 08/2010 - 12/2007
2	Messenger RNA (mRNA)IBA 05/2003 - 05/2002
1	enzalutamideIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023
1	Bevacizumab (Avastin)FDA Link 04/2023
1	BMS 754807IBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2018
1	ChromatinIBA 01/2018
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 10/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Brachyury protein (Brachyury)IBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 11/2015
1	Histones (Histone)IBA 11/2015
1	adavosertibIBA 11/2015
1	AZ 12253801IBA 06/2015
1	Cisplatin (Platino)FDA LinkGeneric 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 06/2012
1	EnzymesIBA 09/2011
1	Fumarate Hydratase (Fumarase)IBA 09/2011
1	TOR Serine-Threonine KinasesIBA 06/2009
1	Sirolimus (Rapamycin)FDA Link 06/2009
1	RNA (Ribonucleic Acid)IBA 12/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2007
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2005
1	Small Interfering RNA (siRNA)IBA 01/2005
1	OligonucleotidesIBA 05/2003
1	Antisense OligonucleotidesIBA 05/2003
1	Insulin Receptor Substrate ProteinsIBA 05/2002
1	Cadherins (E-Cadherin)IBA 05/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2008
4	Radiotherapy 11/2019 - 06/2015
2	Drug Therapy (Chemotherapy) 06/2015 - 10/2014
1	Castration 10/2023
1	Laryngectomy 11/2019